Log in to save to my catalogue

SGLT2 inhibitors and lower limb complications: an updated meta-analysis

SGLT2 inhibitors and lower limb complications: an updated meta-analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7f3ae892f544b26b26dc73b603938ea

SGLT2 inhibitors and lower limb complications: an updated meta-analysis

About this item

Full title

SGLT2 inhibitors and lower limb complications: an updated meta-analysis

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2021-04, Vol.20 (1), p.91-91, Article 91

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

To exam the associations between the use of sodium glucose co-transporter 2 inhibitor (SGLT2i) and the risk of lower limb complications, and to analyze the associated factors.
Pubmed, Medline, Embase, the Cochrane Center Register of Controlled Trials for Studies and Clinicaltrial.gov were searched from the inception to November 2020. Randomized...

Alternative Titles

Full title

SGLT2 inhibitors and lower limb complications: an updated meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d7f3ae892f544b26b26dc73b603938ea

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7f3ae892f544b26b26dc73b603938ea

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-021-01276-9

How to access this item